Thymic Epithelial Malignancies
Showing 1 - 25 of 4,726
Thymic Epithelial Tumor Trial (HITOC)
Recruiting
- Thymic Epithelial Tumor
- HITOC
-
Shanghai, ChinaShanghai Zhongshan Hospital
Sep 15, 2022
Molecular Analysis and Treatment Options of Thymic Malignancies
Recruiting
- Thymic Epithelial Tumor
- +2 more
-
Shanghai, Shanghai, ChinaXiaomin Niu
Dec 28, 2022
Cancer Trial (single arm for all patients)
Not yet recruiting
- Cancer
- single arm for all patients
- (no location specified)
Sep 26, 2022
Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)
Recruiting
- Thymic Epithelial Tumor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)
Recruiting
- Thymoma
- Radiotherapy Combined with GM-CSF
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 2, 2022
Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)
Active, not recruiting
- Thymoma and Thymic Carcinoma
- Thymosin a1
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Nov 27, 2021
NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- AZD6244
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Thymic Malignancies, Pleural Metastases Trial in United States (Intensity-Modulated Pleural Radiation Therapy (IMPRINT))
Recruiting
- Thymic Malignancies
- Pleural Metastases
- Intensity-Modulated Pleural Radiation Therapy (IMPRINT)
-
Basking Ridge, New Jersey
- +6 more
May 2, 2022
Caregiver, Malignant Pleural Tumor, Metastatic Thymic Carcinoma Trial in Columbus (Palliative Therapy, Questionnaire
Completed
- Caregiver
- +11 more
- Palliative Therapy
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 11, 2022
NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +10 more
-
Singapore, SingaporeNovartis Investigative Site
Nov 16, 2022
Gynecologic Tumors, Epithelial Ovarian Cancer Trial in Canada, United States (PLX2853, Carboplatin)
Terminated
- Gynecologic Neoplasms
- Epithelial Ovarian Cancer
-
Chicago, Illinois
- +8 more
Jul 19, 2022
Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation
Recruiting
- Tumor Recurrence
- +3 more
- carbon ion radiation therapy
-
Pavia, Pv, ItalyCNAO
Jul 13, 2022
Poor Thymic Function, Immunodeficiency, Athymia Trial (biological, procedure, drug)
Approved for marketing
- Poor Thymic Function
- +5 more
- Cultured Thymus Tissue
- +2 more
- (no location specified)
Mar 23, 2022
Rapid Autopsy and Procurement of Cancer Tissue
Recruiting
- Thymus Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Thymic Epithelial Tumor Trial in Seoul (pembrolizumab, Radiation)
Recruiting
- Thymic Epithelial Tumor
- pembrolizumab
- Radiation
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 18, 2021
Cardiotoxicity, Pulmonary Toxicity, Thymus Tumors Trial in Umeå, Stockholm, Gothenburg (Proton radiation)
Recruiting
- Cardiotoxicity
- +2 more
- Proton radiation
-
Umeå, Norrland, Sweden
- +2 more
Mar 25, 2021
Thymic Epithelial Tumor Trial (Toripalimab, Chemotherapy)
Not yet recruiting
- Thymic Epithelial Tumor
- (no location specified)
Jan 25, 2021
Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)
Not yet recruiting
- Untreated Advanced or Recurrent Thymic Carcinomas
- MK-3475
- +3 more
-
Chuo, Tokyo, JapanNational Cancer Center Hospital
Apr 16, 2023
Thymic Carcinoma, Thymoma Trial in Milan (Ramucirumab)
Recruiting
- Thymic Carcinoma
- Thymoma
- Ramucirumab
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Nov 12, 2020
Sarcomas, Melanomas, Germ Cell Tumors Trial run by the NCI (AeroEclipse II Breath Actuated Nebulizer, Bintrafusp alfa,
Withdrawn
- Sarcomas
- +4 more
- AeroEclipse II Breath Actuated Nebulizer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 16, 2021
l, Laboratory and Epidemiologic Characterization of Individuals
Completed
- Familial Ovarian Cancer
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 31, 2022
Molecular Analysis of Thoracic Malignancies
Enrolling by invitation
- Thymus Cancer
- +5 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 8, 2021
Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)
Recruiting
- Ovarian Cancer, Epithelial
- +14 more
-
Sutton, Surrey, United Kingdom
- +6 more
Jul 22, 2022
Thymic Epithelial Tumor Trial in Shanghai (rhGM-CSF,Peginterferon alfa-b2,radiation)
Not yet recruiting
- Thymic Epithelial Tumor
- rhGM-CSF,Peginterferon alfa-b2,radiation
-
Shanghai, Shanghai, ChinaFudan University shanghai cancer center
Aug 16, 2020